Aerpio Pharmaceuticals, Inc. announced that Michael Rogers has been appointed Chief Financial Officer effective as of November 15, 2017. Mr. Rogers has more than 25 years of experience in the biopharmaceutical industry, serving as Chief Financial Officer of five publicly-traded healthcare companies. He most recently served as CFO at Acorda Therapeutics, a biopharmaceutical company from 2013 until 2016. Prior to Acorda Therapeutics, he was the Executive Vice President and CFO of BG Medicine from 2009 to 2012. He currently serves as Chairman of the Board of Directors of Keryx Pharmaceuticals and as a member of the Board of Directors for pSivida Corp.